INTRODUCING SAFEPUSH
MAKING PATIENT CARE SAFE AND SOLVING THE IV PUSH PROBLEM
OUR STORY
How We Got Here
I am a nurse and attorney. I had a client named Michael who was hospitalized and needed IV Push injections. Unfortunately, Michael was given an IV Push injection too fast by a healthcare provider. Michael lost the use of his arm and hand because the IV Push injection was administered too rapidly.
I saw the devastation that this had on both Michael and his family. This was a human error that is preventable. Today there are no safe or expeditious methods/devices to prevent this from happening. SafePush is a medical device that will eliminate human error and eliminate the IV Push Problem.
Tonia Aiken,RN,BSN,JD
Co-CEO SafePush
THE PROBLEM
IV Push Medications Given Too Fast
93% of IV injection errors of critical care drugs are because injections are given too fast. Standard methods to regulate injection rate are guesstimating or Clock Watching which result in human errors leading to lethal or catastrophic injuries. ER provider focus groups and surveys validate the need to replace current ineffective and dangerous practices with new, innovative technology that increases patient safety when administering IV Push injections of critical care drugs.
OUR TECHNOLOGY
Safepush Solutions
SafePush™ is an easy to use, disposable patented device that removes the guesswork in timed delivery of critical care IV Push drug injections and the potential for human error.
.png){kind=small}
Disposable
.png){kind=small}
Affordable
.png){kind=small}
Prevents Human Error
TONIA AIKEN - RN, BSN, JD
Co-CEO, Medical
KEVIN EDWARDS
Co-CEO, Business, GTM & Marketing
JAMES AIKEN - MD, FACEP, MHA
Chief Medical Officer
KENNY PERRY - BSME
Chief Design Engineer
TINA MAYES - CLU, CHFC, MBA
Treasurer
PARTNERS
The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is a FDA funded pediatric medical device accelerator centered at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC). Established in 2011 and first funded by the U.S. Food and Drug Administration (FDA) in 2013, CTIP promotes the commercialization and clinical use of pediatric medical device technology.
CTIP addresses the most important component missing from pediatric device innovation: simultaneously engaging clinicians, engineers, regulators, hospital administrators, patients and the business community in the process of assessment and development of technology. For portfolio companies, CTIP fosters networking opportunities, direct and indirect financial support and guidance on issues related to, but not limited to, intellectual property, prototyping, engineering, testing, grant writing and clinical trial design. CTIP has a network of children’s hospitals, academic institutions, accelerators and incubators across the West Coast to support the commercialization of pediatric medical devices. CTIP network members include the University of California, Los Angeles; Oregon Health & Science University; University of Southern California; University of California, San Diego; University of California, Berkeley; Seattle Children’s Hospital; Cedars-Sinai Accelerator; The Lundquist Institute; Project Zygote and Larta Institute.
Proudly serving as the MedTech industry’s premier CRO partner for cost-efficient and efficacious outcomes that lead to accelerated development and marketplace success. NAMSA provides unparalleled medical device testing capabilities, strategic guidance and tactical support to fast-track market introduction. We are committed to helping Clients overcome development hurdles, mitigate concerns and streamline commercialization efforts. From concept to post-market, we are proud to fully support Clients through the delivery of exceptional outcomes throughout every stage of the MedTech development continuum.
Founded in 2002, Gilero began as an engineering design firm with a focus on single-use medical device products. Since then, Gilero has grown into a one-stop shop for the design, development and contract manufacturing of everything from consumable medical devices to complex electromechanical drug delivery systems.
The Largest Accelerator of Medical Devices in the World. MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. SafePush is in the top 25 Accelerator Companies @ Medtech
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 480+ life sciences corporate partnering and licensing deals since 2010 - 1,000+ M&A transactions for an aggregate value of $465+ billion since 2019 #1 law firm for tech and life sciences IPOs - 370+ funds formed with $34+ billion raised in 2020
The Infusion Nurses Society (INS) is an international nonprofit organization representing infusion nurses and other clinicians who are engaged in the specialty practice of infusion therapy. Since 1973, INS has continued its commitment to bringing innovative resources and learning opportunities to the wide range of health care professionals involved in the specialty practice of infusion therapy. We are dedicated to advancing the delivery of quality infusion therapy to patients, enhancing the specialty through stringent standards of practice and professional ethics, and promoting research and education in the infusion nursing practice. Recognized as the global authority in infusion therapy, INS is dedicated to exceeding the public’s expectations of excellence by setting the standard for infusion care. SafePush received the 2022 Innovation Award.
We help teams bring high-quality, life-saving products to market and scale successfully. Life sciences companies need a secure and scalable quality management system with the flexibility to support their evolving needs. Qualio meets that challenge with an enterprise-class cloud QMS that cuts through complexity to optimize and automate your critical quality processes.
.png)
AdvaMed's member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce healthcare technology both in the United States and around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies.
ACCELERATOR PROGRAMS
